The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Borges Almeida, Eliane ^a   Milanez, Helaine M B P M ^a   Vilela, Maria Marluce S ^a   Cunha, Fernanda G P ^a   Abramczuk, Beatriz M ^a   Reis Alves, Suiellen C ^a   Metze, Konradin ^a   Lorand Metze, Irene ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD19 ANTIBODY; CD5 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE CULTURE; LYMPHOCYTE SUBPOPULATION; MATERNAL AGE; MATERNAL DISEASE; MATERNAL SMOKING; NEWBORN; NEWBORN ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRE B LYMPHOCYTE; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PROSPECTIVE STUDY; TERM BIRTH; UMBILICAL CORD BLOOD; BLOOD; DISEASE TRANSMISSION; FETUS BLOOD; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MALE; PREGNANCY; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION; VIROLOGY;

ADULT; CYTOKINES; FEMALE; FETAL BLOOD; HIV; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LYMPHOCYTE SUBSETS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79551524370     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-38     Document Type: Article

References (40)

1. Blanche S, Rouzioux C, Moscato MLG, Veber F, Mayaux MJ, Jacomet C, Joëlle Tricoire J, Deville A, Vial M, Firtion G, Crepy A, Douard D, Robin M, Courpotin C, Ciraru-Vigneron N, Deist F, Griscelli C, . the HIV Infection in Newborns French Collaborative Study Group A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989, 320:1643-1648. 10.1056/NEJM198906223202502, 2657430, the HIV Infection in Newborns French Collaborative Study Group.
2. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, Villa ML, Ferrante P, Dally L, Vigano A. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000, 96:3866-3871.
3. Müller F, Tjonnfjord GE, Nordoy I, Kvale D, Mellbye OJ, Aukrust R, Froland SS. Immunophenotypic analyses of CD34+ cell subsets in bone marrow from HIV-infected patients during highly-active antiretroviral therapy. Eur J Clin Invest 2002, 32:535-540.
4. Pacheco SE, McIntosh K, Ming L, Mofenson LM, Diaz C, Foca M, Frederick M, Handelsman E, Hayani K, Shearer WT, . Women and Infants Transmission Study Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study. J Infect Dis 2006, 194:1089-1097. 10.1086/507645, 16991083, Women and Infants Transmission Study.
5. Newell ML, Huang S, Fiore S, Thorne C, Mandelbrot L, Sullivan JL, Maupin R, Delke I, Watts DH, Gelber RD, Cunningham CK, . PACTG 316 Study Team Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007, 7:60. 10.1186/1471-2334-7-60, 1913528, 17584491, PACTG 316 Study Team.
6. Sachdeva N, Oshima K, Cotter A, Ashman M, Davila L, Okazaki T, Inaba N, Asthana D. Analysis of immunological markers associated with pregnancy and HIV-1 infection: relevance in perinatal transmission in HIV-1-infected pregnant women with low plasma viral load. Am J Reprod Immunol 2008, 60:264-273. 10.1111/j.1600-0897.2008.00627.x, 18647287.
7. Thorne C, Semenenko I, Pilipenko T, Malyuta R, . Ukraine European Collaborative Study Group Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study. BMC Infect Dis 2009, 9:40. 10.1186/1471-2334-9-40, 2674441, 19351387, Ukraine European Collaborative Study Group.
8. Feola DJ, Garvy BA. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B lymphocyte immune responses to Pneumocystis murina infection in healthy mice. Clin Vaccine Immunol 2006, 13:193-201. 10.1128/CVI.13.2.193-201.2006, 1391936, 16467325.
9. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sørensen TU, Dreves AM, Ersbøll AK, Ryder LP, Valerius NH, Nielsen JO. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001, 98:398-404. 10.1182/blood.V98.2.398, 11435309.
10. Ono E, Nunes dos Santos AM, Succi RCM, Machado DM, de Angelis DSA, Salomão R, Kallás EG, de Moraes-Pinto MI. Imbalance of naïve and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res 2008, 41:700-708. 10.1590/S0100-879X2008000800011, 18797705.
11. Bunders M, Thorne C, Newell ML, . the European Collaborative Study Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005, 19:1071-1079. 10.1097/01.aids.0000174454.63250.22, 15958839, the European Collaborative Study.
12. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RCM, Salomão R, Kallás EG, de Moraes-Pinto MI. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Cytometry B 2007, 72:14-21.
13. Carniel EF, Morcillo AM, Blotta MH, Da Silva MTN, Mazzola TN, Antonio MA, Zanolli ML, Netto AA, Higashi HG, Raw I, Vilela MM. Immunogenicity and safety of combined intradermal recombinant hepatitis B with BCG vaccines at birth. Vaccine 2008, 26:647-652. 10.1016/j.vaccine.2007.11.048, 18155811.
14. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Sthiem ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA, . Pediatric AIDS Clinical Trials Group Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatrics AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003, 112:973-980. 10.1016/j.jaci.2003.07.003, 14610491, Pediatric AIDS Clinical Trials Group.
15. Fiore S, Newell ML, Trabattoni D, Thorne C, Gray L, Savasi V, Tibaldi C, Ferrazzi E, Clerici M. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol 2006, 70:143-150. 10.1016/j.jri.2005.12.001, 16423410.
16. Adam RL, Silva RC, Pereira FG, Leite NJ, Lorand-Metze I, Metze K. The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia. Cell Oncol 2006, 28:55-59.
17. Rybka MO, Cintra ML, de Souza EM, Metze K. Density of dendritic cells around basal cell carcinomas is related to tumor size, anatomical site and stromal characteristics, and might be responsible for the response to topical therapy. Int J Dermatol 2008, 47:1240-4. 10.1111/j.1365-4632.2008.03808.x, 19126008.
18. Lorand-Metze I, Meira DG, Lima CS, Vassallo J, Metze K. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia. Haematologica 1999, 84:564-565.
19. Faye A, Pornprasert S, Mary JY, Dolcini G, Derrien M, Barré-Sinoussi F, Chaouat G, Menu E, . the ANRS 1267 study team and the HIV-1 PMTCT-PlaNet Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol 2007, 149:430-439. 10.1111/j.1365-2249.2007.03411.x, 2219329, 17511776, the ANRS 1267 study team and the HIV-1 PMTCT-PlaNet.
20. Hygino J, Lima PG, Filho RGS, Silva AAL, Saramago CSM, Andrade RM, Andrade DM, Andrade AF, Brindeiro R, Tanuri A, Bento CA. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol 2008, 127:340-347. 10.1016/j.clim.2008.01.020, 18356112.
21. Resino S, Galán R, Correa R, Pajuelo J, Bellón JM, Munoz-Fernandez MA. Homeostatic role of IL7 in HIV-1 infected children on HAART: association with immunological and virological parameters. Acta Paediatr 2005, 94:170-177. 10.1080/08035250410020208, 15981750.
22. Sadeghi M, Susal C, Daniel V, Naujokat C, Zimmermann R, Huth-Kuhne A, Opelz G. Decreasing soluble CD30 and increasing IFNγ plasma levels are indicators of effective highly active antiretroviral therapy. AIDS Res Hum Retrov 2007, 23:886-890.
23. Redgrave BE, Stone SF, French MAH, Krueger R, James IR, Price P. The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med 2005, 6:307-312. 10.1111/j.1468-1293.2005.00312.x, 16156877.
24. Sampaio A, López-Gómez M, Jimenez-Alonso J, Ortiz F, Samaniego F, Garrido F. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease. Clin Immunol Immunopathol 1993, 66:260-268. 10.1006/clin.1993.1034, 7679344.
25. Meira DG, Lorand-Metze I, Toro ADC, Silva MTN, Vilela MMS. Bone marrow features in children with HIV infection and peripheral blood cytopenias. J Trop Pediatr 2005, 51:114-119. 10.1093/tropej/fmh096, 15840762.
26. Halonen M, Lohman IC, Stern DA, Spangenberg A, Anderson D, Mobley S, Ciano K, Peck M, Wright AL. Th1/Th2 patterns and balance in cytokine production in the parents and infants of a large birth cohort. J Immunol 2009, 182:3285-3293. 10.4049/jimmunol.0711996, 19234227.
27. Barbaro G, Iacobellis G. Metabolic syndrome associated with HIV and highly active antiretroviral therapy. Current Diabetes Reports 2009, 9:37-42. 10.1007/s11892-009-0008-7, 19192423.
28. Pornprasert S, Mary JY, Faye A, Leechanachai P, Limtrakul A, Rugpao S, Sirivatanapa P, Gomuthbutra V, Matanasaravoot W, Le CS, Lallemant M, Barré-Sinoussi F, Menu E, Ngo-Giang-Huong N, . ANRS 1267 study team and HIV-1 PMTCT-PlaNet Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine. Curr HIV Res 2009, 7:211-217. 10.2174/157016209787581472, 19275589, ANRS 1267 study team and HIV-1 PMTCT-PlaNet.
29. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of non-adherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine&Tobacco Res 2008, 10:731-736.
30. Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Meléndez LM, Lasalde-Dominicci J. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus- seropositive women. J Neurovirol 2007, 13:561-568. 10.1080/13550280701620747, 18097887.
31. De Maria A, Cirillo C, Moretta L. Occurrence of HIV-1 specific cytolitic T cell activity in apparently uninfected children born to HIV-1 infected mothers. J Infect Dis 1994, 170:1296-1301.
32. Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis 2002, 34:267-276. 10.1086/338153, 11740717.
33. Malamitsi-Puchner A, Protonotariou E, Boutsikou T, Makrakis E, Sarandakou A, Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Human Development 2005, 81:387-392. 10.1016/j.earlhumdev.2004.10.017, 15814224.
34. Malaspina A, Moir S, Ho J, Wang W, Howell ML, O'Shea MA, Roby GA, Rehm CA, Mican JM, Chun TW, Fauci AS. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. PNAS 2006, 103:2262-2267. 10.1073/pnas.0511094103, 1413756, 16461915.
35. Metze K, Maciel JA. AIDS and Chagas' disease. Neurology 1993, 43:447-448.
36. Viganò A, Zuccotti GV, Pacci M, Erba P, Castelletti E, Giacomet V, Amendola A, Pariani E, Tanzi E, Clerici M. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr 2008, 48:289-296.
37. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002, 100:4537-4543. 10.1182/blood-2002-05-1525, 12393419.
38. Durandy A, Thuillier L, Forveille M, Fischer A. Phenotypic characteristics of human newborns' B lymphocytes. J Immunol 1990, 144:60-65.
39. van Lochen EG, van der Velden VHJ, Wind HK, te Marvelde JG, Westerdaal NAC, van Dongen JJM. Immunophenotypic differentiation of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B 2004, 60B:1-13.
40. Karlix J, Behnke M, Davis-Eyler F, Wobie K, Adams V, Freiburger B, Conlon M, Tebbett I. Cocaine Suppresses Fetal Immune System. Ped Res 1998, 44:43-46.